In SS, subtle defects in potentially any number of pathways including immune response, antigen processing and/or the trafficking of Ro52 peptides in antigen-presenting cells, may allow for enhanced pathogen-complex presentation on the cell surface. The gene discussed is TRIM21; the disease is synovial sarcoma.